Cook N, Hansen AR, Siu LL, Abdul Razak AR. Early phase clinical trials to identify optimal dosing and safety. Mol Oncol 2015;9(5):997–1007. DOI: 10.1016/j.molonc.2014.07.025.
Smith BS, Yogaratnam D, Levasseur-Franklin KE, Forni A, Fong J. Introduction to drug pharmacokinetics in the critically ill patient. Chest 2012;141(5):1327–1336. DOI: 10.1378/chest.11-1396.
Kang J-S, Lee M-H. Overview of therapeutic drug monitoring. Korean J Intern Med 2009;24(1):1–10. DOI: 10.3904/kjim.2009.24.1.1.
Theodore WH, Yu L, Price B, Yonekawa W, Porter RJ, Kapetanovic I, et al. The clinical value of free phenytoin levels. Ann Neurol 1985;18(1):90–93. DOI: 10.1002/ana.410180116.
Tozer TN, Winter ME. Phenytoin. In: Evans WE, editor. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. 3rd ed. Vancouver (WA): Applied Therapeutics Inc.; 1992. pp. 25.1–25.44.
Khandelwal V, Sharma S. Fatal MDR Klebsiella in ICU — How was it Dealt with? Indian J Crit Care Med 2019;23(9):411–413. https://www.ijccm.org/doi/IJCCM/pdf/10.5005/jp-journals-10071-23235.
